Roche Holding Ag:
* ROCHE UNIT CHUGAI SAYS GETS JAPANESE APPROVAL OF TECENTRIQ FOR TREATMENT OF UNRESECTABLE, ADVANCED OR RECURRENT NON-SMALL CELL LUNG CANCER Source text for Eikon: Further company coverage:
 